Pages
Investing in disaster
Helen Palmer Sep 1, 2007
One of Silicon Valley's biggest venture capital firms will invest $200 million into a pandemic and bio-defense fund. The VC fund also invested in Google and Amazon. Helen Palmer looks into whether its latest idea has legs.
Killer prices?
Sep 1, 2007
Genentech's drug Avastin is a highly effective treatment for colon, breast, and lung cancer. It's also incredibly expensive. Genentech says society has to be willing to pay more for the benefits of life-sustaining drugs, but Commentator Jamie Court says drug companies have a moral obligation not to price them out of reach.
Bird flu in Germany
Stephen Beard Sep 1, 2007
Germany has become the latest European country to confirm that bird flu has reached its territory. Two dead swans were found to have the H5N1 virus. Veterinary experts have begun a 2-day meeting in Brussels to discuss further measures to combat the disease. From the European Desk in London, Stephen Beard reports.
Medicaid to Medicare
Amy Scott Sep 1, 2007
Today the federal government stops reimbursing states that picked up the tab during the Medicare prescription drug debacle earlier this year. Amy Scott repots on whether states have succeeded in moving eligible seniors off Medicaid rolls and into the new program.
Managing cancer
Helen Palmer Sep 1, 2007
A new book out says that in the future, cancer will be a manageable disease, not unlike diabetes. But as Helen Palmer reports, managing cancer won't be affordable for everyone.
Flu season update
Helen Palmer Sep 1, 2007
The Centers for Disease Control report flu rates this year are down, compared to last year. Does that mean fewer sick days for employees and more productive businesses? Helen Palmer takes a look.
Bird flu comes to Africa
Helen Palmer Sep 1, 2007
Two more cases of bird flu have been confirmed in Nigeria. This comes a day after the first outbreak of the H5N1 virus was reported in Africa. There are worries that sub-Saharan Africa lacks the infrastructure to deal with a massive health crisis. Helen Palmer has the story.
The Ritalin Generation
Youth Radio Sep 22, 2011
Many of today's college students have grown up with a personal knowledge of ADD drugs. There's even a name for them: "The Ritalin Generation." Some students are abusing these medications, either for study aids or for a good time. Youth Radio's Michelle Jarboe reports from the University of North Carolina at Chapel Hill, where she says there is a thriving black market for ADD drugs.
The FDA and ADD
Helen Palmer Sep 1, 2007
Senator Chuck Grassley is charging that the Food and Drug Administration isn't regulating prescription drugs for Attention Deficit Hyperactivity Disorder (ADD). His remarks come as two FDA advisory panels prepare to meet to discuss ADD drugs. Helen Palmer has the story.
Asbestos lawsuits bill
Sep 1, 2007
The Senate is set to vote today on whether to consider a bill to halt asbestos lawsuits. The bill's prompted intense lobbying and many observers don't expect it to pass. Eric Niiler reports on what happens next, if and when the bill dies.
